Abu Dhabi: A total of 51,100 COVID-19 tests have been conducted in Abu Dhabi International Airport covering passengers, airline crew members and employees of the airport since the first week of February in the wake of the global spread of the pandemic.
As part of the extensive health and safety measures implemented across the facility, Abu Dhabi International Airport partnered with Pure Health, the largest laboratory operator in the GCC, which managed the massive COVID-19 screening initiative covering the 24/7 operations at the airport.
During the period of various restrictions and the suspension of passenger flight services, the airport remained open for vital cargo operations serving capacity-constrained markets, special repatriation flights and facilitating global humanitarian relief efforts.
Commenting on the project, Mohammed Husain Ahmed, General Manager of Abu Dhabi International Airport, said: “We are delighted to have partnered with Pure Health to establish a comprehensive COVID-19 screening program across the international airport. Our testing program was established in coordination with the relevant authorities and designed to bolster our collective efforts to protect public health during this challenging time.”
“Operations at the airport have continued smoothly and efficiently despite the robust precautionary measures in place including social distancing, the mandatory use of personal protective equipment (PPE), thermal screening, and nasal swab and polymerase chain reaction (PCR) testing in line with the recommendations and guidelines of the UAE’s health and civil aviation authorities in addition to the World Health Organization (WHO),” added Ahmed.
Abu Dhabi Airports was among the first airport groups to implement a comprehensive testing regime across its facilities. Today, following the introduction of other advanced new technologies including touchless elevator controls, sterilisation robots, thermal cameras equipped with artificial intelligence (AI), and self-cleaning escalator handrails, Abu Dhabi International Airport is supporting the gradual resumption of commercial flights from the UAE’s capital.
Commenting on the project, Shaista Asif, Chief Operating Officer at Pure Health, said, “We are proud to partner with Abu Dhabi Airports and offer our expertise of global standards to screen its staff members, airline crew members and passengers arriving at the airport since the beginning of the COVID-19 outbreak. So far, a total of 51,000 tests were performed.”
“For the project, we set up a special diagnostic system at the airport with registration desks for patients connected with passport and Emirates ID scanners, leading to the swab screening area managed by highly trained medical professionals. The system includes logistics and supply chain channels of Pure Health’s supply centre and a specialized laboratory,” she added.
Dr. Gurdeep Dhatt, Chief Medical Officer at Pure Health, said, “Our system ensured that the airport operation had all the supplies needed to go on uninterrupted and that all the samples reached the lab in line with international standards and procedures in the shortest amount of time, ensuring a quick turnaround time.”
“We have been collaborating with healthcare providers and authorities in this screening initiative across the nation since the beginning. Pure Health has been conducting COVID-19 tests in more than 15 collection centres and two processing locations in the UAE,” he added.
Pure Health has the largest COVID-19 testing capability in Middle East, Africa and South Asia with the capacity to perform 60,000 tests daily. Furthermore, the company is continuously building capacity in its labs and is ready to support the airport with large volumes of passengers arriving to the UAE. The pioneering healthcare solutions provider runs the largest laboratory network in the entire Gulf region with 117 labs and employing over 750 healthcare professionals across the nation.
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
